Pharmaceutical Manufacturing of Ibuprofen Tablets

The contract encompasses the full-scale manufacturing of 10 million ibuprofen tablets, covering all stages from formulation and tablet compression to final coating and comprehensive quality control testing, all in strict alignment with government specifications. The production must adhere to rigorous regulatory standards to ensure safety, efficacy, and consistency, with every batch subjected to verified analytical and physical testing protocols. The work is contracted under the Defense Logistics Agency, a component of the Department of Defense, and falls under the NAICS code 325412 for pharmaceutical preparation manufacturing. Although no set-aside classification is specified and the place of performance details are unprovided, the contract is structured as a subcontract with a solicitation issued on July 14, 2026. The production effort supports a critical government supply chain, likely tied to emergency preparedness or military medical needs, and is linked to the official DLA contract record with reference SPE2DP26F7465.